Analysis of the defect in IFN-γ induction of MHC class II genes in G1B cells: Identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6622-6630

  Brickey, W June ^a   Wright, Kenneth L ^a,c   Zhu, Xin Sheng ^b   Ting, Jenny P Y ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REGULATORY FACTOR X; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BARE LYMPHOCYTE SYNDROME; DNA BINDING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE ISOLATION; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TRANSACTIVATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BASE PAIRING; BASE SEQUENCE; CLONING, MOLECULAR; CYSTEINE; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS II; GENETIC COMPLEMENTATION TEST; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LEUCINE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032715354     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Mao, C., D. Davies, I. M. Kerr, and G. R. Stark. 1993. Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon γ. Proc. Natl. Acad. Sci. USA 90:2880.
2. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
3. Ting, J. P.-Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
4. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
5. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
6. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
7. Abdulkadir, S. A., and S. J. Ono. 1995. How are class II MHC genes turned on and off? FASEB J. 9:1429.
8. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the hare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today 16: 539.
9. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
10. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
11. Brown, A. M., C. L. Barr, and J. P. Ting. 1991. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-γ-induced expression of human class II-associated invariant chain gene. J. Immunol. 146:3183.
12. Vilen, B. J., J. F. Penta, and J. P.-Y. Ting. 1992. Structural constraints within a trimeric transcriptional regulatory region: constitutive and interferon-γ inducible expression of the HLA-DRA gene. J. Biol. Chem. 267:23728.
13. Ting, J. P.-Y., K. L. Wright, K.-C. Chin, W. J. Brickey, and G. Li. 1997. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression. J. Immunol. 159:5457.
14. Reith, W., E. Barras, S. Satola, M. Kobr, D. Reinhart, C. H. Sanchez, and B. Mach. 1989. Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc. Natl. Acad. Sci. USA 86:4200.
15. Moreno, C. S., E. M. Rogers, J. A. Brown, and J. M. Boss. 1997. Regulatory factor X, a hare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158:5841.
16. Zeleznik-Le, N., J. C. Azizkhan, and J. P.-Y. Ting. 1991. Affinity-purified CCAAT-box-binding prolein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873.
17. Hasegawa, S. L., and J. M. Boss. 1991. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:6269.
18. Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. P.-Y. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042.
19. Linhoff, M. W., K. L. Wright, and J. P.-Y. Ting. 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589.
20. Calman, A. F., and B. M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489.
21. Benichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
22. Loh, J. E., C. H. Chang, W. L. Fodor, and R. A. Flavell. 1992. Dissection of the interferon γ-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s). EMBO J. 11: 1351.
23. Seidl, C., C. Saraiya, Z. Osterweil, Y. P. Fu, and J. S. Lee. 1992. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1576.
24. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
25. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
26. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045.
27. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P.-Y. Ting. 1995. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:20978.
28. Maity, S. N., and B. de Crombrugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem. Sci. 23:174.
29. Reith, W., C. Ucla, E. Barras, A. Gaud, B. Durand, C. Herrero-Sanchez, M. Kobr, and B. Mach. 1994. RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell. Biol. 14:1230.
30. Emery, P., B. Durand, B. Mach, and W. Reith. 1996. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res. 24:803.
31. Emery, P., M. Strubin, K. Hofmann, P. Bucher, B. Mach, and W. Reith, 1996. A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol. Cell. Biol. 16:4486.
32. Durand, B., M. Kobr, W. Reith, and B. Mach. 1994. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol. Cell. Biol. 14:6839.
33. Reith, W., S. Satola, C. H. Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897.
34. Herrero-Sanchez, C., W. Reith, P. Silacci, and B. Mach. 1992. The DNA binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell. Biol. 12:4076.
35. Hasegawa, S. L., J. L. Riley, J. H. Sloan III, and J. M. Boss. 1993. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells. J. Immunol. 150:1781.
36. Accolla, R. S. 1983. Human B cell variants immunoselected against a single la antigen subset have lost expression of several la antigen subsets. J. Exp. Med. 157:1053.
37. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA pol II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
38. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
40. Chin, K.-C., G. X. Li, and J. P.-Y. Ting. 1997. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal CIITA deletion mutants. J. Immunol. 159:2789.
41. Sherman, P. A., P. V. Basta, T. L. Moore, A. M. Brown, and J. P.-Y. Ting. 1989. Class II box consensus sequences in the HLA-DRA gene: transcriptional function and interaction with nuclear proteins. Mol. Cell. Biol. 9:50.
42. Sherman, P. A., P. V. Basta, and J. P.-Y. Ting. 1987. Upstream DNA sequences required for tissue-specific expression of the HLA-DRA gene. Proc. Natl. Acad. Sci. USA 84:4254.
43. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
44. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoter in the bare lymphocyte syndrome. Science 252:709.
45. Sen, C. K., and L. Packer. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709.
46. Velazquez, L., M. Fellous, G. R. Stark, and S. Pellegrini. 1992. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313.
47. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
48. Briscoe, J., D. Guschin, N. C. Rogers, D. Watling, M. Muller, F. Horn, P. Heinrich, G. R. Stark, and I. M. Kerr. 1996. JAKs. STATs and signal transduction in response to the interferons and other cytokines. Philos. Trans. R. Soc. London B 351:167.
49. Kneller, D. G., F. E. Cohen, and R. Langridge. 1990. Improvements in protein secondary structure prediction by an enhanced neural network. J. Mol. Biol. 214: 171.
50. Solovyev, V. V., and A. A. Salamov. 1994. Predicting α-helix and β-strand segments of globular proteins. Comput. Appl. Biosci. 10:661.
51. Wedel, A., and H. W. Ziegler-Heitbrock. 1995. The C/EBP family of transcription factors, Immunobiology 193:171.
52. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177.
53. Buchanan, S. G. S. C., and N. J. Gay. 1996. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65:1.
54. lozzo, R. V. 1997. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32:141.
55. Li, C., S. E. Martin, and G. J. Roth. 1995. The genetic defect in two well-studied cases of Bernard-Soulier syndrome: a point mutation in the fifth leucine-rich repeat of platelet glycoprotein Ib α. Blood 86:3805.
56. Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and M. G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677.
57. Rowland, O., and J. Segall. 1998. A hydrophobic segment within the 81-amino-acid domain of TFIIIA from Saccharomyces cerevisiae is essential for its transcription factor activity. Mol. Cell. Biol. 18:420.
58. Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020.
59. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330.
60. Louis-Plence, P., C. S. Moreno, and J. M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:3899.
61. Vilen, B. J., J. P. Cogswell, and J. P. Ting. 1991. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell. Biol. 11:2406.
62. Jabrane-Ferrat, N., J. D. Fontes, J. M. Boss, and B. M. Peterlin. 1996. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16:4683.
63. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
64. Westerheide, S. D, P. Louis-Plence, D. Ping, X. F. He, and J. M. Boss. 1997. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158:4812.